HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taylor S Cohen Selected Research

Taylor S Cohen Research Topics

Disease

11Infections
01/2022 - 01/2013
7Pneumonia (Pneumonitis)
01/2021 - 01/2012
4Inflammation (Inflammations)
01/2019 - 06/2011
4Sepsis (Septicemia)
01/2018 - 06/2010
3Alcoholic Fatty Liver
01/2023 - 09/2019
2COVID-19
03/2024 - 02/2024
2Body Weight (Weight, Body)
03/2024 - 01/2023
2Fatty Liver
01/2023 - 01/2020
2Thrombosis (Thrombus)
01/2022 - 12/2021
2Thrombocytopenia (Thrombopenia)
01/2022 - 12/2021
2Bacterial Infections (Bacterial Infection)
01/2020 - 01/2016
2Superinfection
01/2019 - 02/2016
2Coinfection
02/2016 - 01/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Non-alcoholic Fatty Liver Disease
01/2020
1Communicable Diseases (Infectious Diseases)
01/2020
1Human Influenza (Influenza)
01/2019
1Surgical Wound Infection
01/2019
1Chronic Obstructive Pulmonary Disease (COPD)
01/2019
1Rheumatoid Arthritis
10/2018
1Persistent Infection
01/2018
1Infectious Arthritis (Septic Arthritis)
01/2017
1Osteomyelitis
01/2017
1Respiratory Tract Infections (Respiratory Tract Infection)
02/2016
1Virus Diseases (Viral Diseases)
01/2016
1Cystic Fibrosis (Mucoviscidosis)
01/2012
1Wounds and Injuries (Trauma)
06/2011

Drug/Important Bio-Agent (IBA)

5Monoclonal AntibodiesIBA
02/2024 - 01/2017
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2017
2cilgavimab and tixagevimab drug combinationIBA
03/2024 - 02/2024
2tixagevimabIBA
03/2024 - 02/2024
2AntibodiesIBA
03/2024 - 05/2017
2cilgavimabIBA
03/2024 - 02/2024
2EndotoxinsIBA
01/2020 - 02/2014
2TitaniumIBA
01/2018 - 01/2017
2InflammasomesIBA
01/2018 - 04/2013
2Interferon LambdaIBA
02/2016 - 01/2016
1SpermidineIBA
01/2023
1PolyaminesIBA
01/2023
1Drinking WaterIBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1ChAdOx1 nCoV-19IBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Heparin (Liquaemin)FDA LinkGeneric
12/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Insulin (Novolin)FDA Link
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1Dietary Fats (Dietary Fat)IBA
09/2019
1Islet Amyloid PolypeptideIBA
09/2019
1LeptinIBA
09/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2019
1p38 Mitogen-Activated Protein KinasesIBA
01/2019
1suvratoxumabIBA
01/2019
1MEDI8852IBA
01/2019
1Secretory Proteinase Inhibitory ProteinsIBA
12/2018
1FlagellinIBA
12/2018
1sivelestatIBA
12/2018
1Toll-Like Receptor 5IBA
12/2018
1Protein-Arginine DeiminasesIBA
10/2018
1AutoantigensIBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1Hemolysin Proteins (Hemolysins)IBA
01/2018
1Immune Sera (Antisera)IBA
05/2017
1salicylhydroxamic acid (SHAM)IBA
01/2017
1factor AIBA
01/2017
1Virulence Factors (Pathogenicity Factors)IBA
03/2016
1InterferonsIBA
02/2016
1Interleukin-22 (IL-22)IBA
02/2016
1LipopolysaccharidesIBA
02/2014
1Interleukin-18 (Interleukin 18)IBA
04/2013
1CytokinesIBA
01/2013
1Interferon Type IIBA
01/2012
1Poly I-CIBA
01/2012
1GelsolinIBA
06/2011
1pyrazolanthroneIBA
06/2010
1U 0126 (UO 126)IBA
06/2010

Therapy/Procedure

2Therapeutics
03/2024 - 01/2021
1Prostheses and Implants (Prosthesis)
01/2018
1Ligation
06/2011
1Punctures
06/2011